I am definitely not intelligent enough to keep up as well as you guys, but on the comment on stemcell trial's only being effective on young, healthy patients, doesn't that fly in the face a little of what another Australian company is seeking to establish in Melbourne?
It seems there are now a couple of trials and results that require some further analysis. The Pfizer one seems to be quite easy to understand (and know that PAR is superior), but the one above I think requires some further understanding.
research reports and media, page-740
-
- There are more pages in this discussion • 3,689 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $187.1K | 755.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47906 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 13363 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |